Rakovina Therapeutics closes $3 million private placement to accelerate drug development

From GlobeNewswire: 2024-12-13 18:50:04

Rakovina Therapeutics Inc. has successfully closed a $3.0 million private placement, consisting of 50,000,000 units at a price of $0.06 per unit. Each unit includes one common share and one common share purchase warrant. Finder’s fees of $180,841 were paid to various firms, and a hold period of four months plus one day applies to all securities issued. The funds raised will be used to accelerate the discovery and development of the company’s proprietary drug candidates. Rakovina has engaged Fairfax Partners Inc. as its Investor Relations partner to enhance market presence and expand the investor base with a comprehensive six-month program.



Read more at GlobeNewswire: Rakovina Therapeutics Announces Closing of Oversubscribed